The BrainArt Exhibition integrates the artistic and scientific worlds, depicting the application of neuroscience in our daily lives. [ + ]

Scientists at Murdoch University have led a study which calculates that all bonds in a DNA strand preserved at the ideal temperature of -5°C would be completely destroyed in bone after approximately 6.8 million years. [ + ]

Two astronomers involved in the Square Kilometre Array telescope project have been recognised at the 2012 WA Science Awards. [ + ]

Nanosonics (ASX:NAN) has been entered as a finalist in the Australian Export Awards, after winning recognition at yesterday's Premier's NSW Export Awards. [ + ]

Benitec Biopharma (ASX:BLT) will acquire Tacere Therapeutics, which has a phase I/II ready hepatitis C treatment candidate developed using Benitec's ddRNAi technology. [ + ]

Bionomics (ASX:BNO) has announced that chairman Chris Fullerton will leave the company at the end of the year, and will be replaced by Graeme Kaufman. [ + ]

The AusBiotech Annual Report 2012, released this week, details another significant period for AusBiotech and for the Australian biotechnology industry. [ + ]

Robert Lefkowitz and Brian Kobilka have received the Nobel Prize in Chemistry for their research into a class of protein receptors that govern many key cellular functions. [ + ]

Life Technologies has announced the acquisition of Compendia Bioscience, a pre-eminent cancer bioinformatics company widely used by the pharmaceutical industry to identify novel gene targets for drug discovery and development. [ + ]

QRxPharma (ASX:QRX) has secured a potentially lucrative licensing deal covering the Canadian market for its pain relief drug, MoxDuo IR, which is currently awaiting marketing approval in Canada and the US. [ + ]

A University of Queensland (UQ) invention that will deliver vaccines without the need for needles has struck a significant partnership with US-based pharmaceutical giant Merck. [ + ]

The McKean Review has reported recently, providing a consultation paper for comment until the end of October. [ + ]

Two pioneers of stem cell science have received the Nobel Prize in Physiology or Medicine "for the discovery that mature cells can be reprogrammed to become pluripotent". [ + ]

Start-up Vaxxas has picked up its first major pre-licensing and evaluation deal for Nanopatch, the needle-free vaccine technology developed at the AIBN, collaborating with Merck. [ + ]

A New Zealand research program being co-funded by the government aims to deliver better seeds and plant species for farmers, in order to help improve animal productivity and minimise environmental impacts. [ + ]